CCLG funds allied health professional research to improve childhood cancer care
Children’s Cancer and Leukaemia Group has funded two new research projects that support non-traditional researchers trying to improve childhood cancer care.
Spotlight on our childhood cancer experts in Southampton
In the UK and Ireland, over 100 childhood cancer researchers have been funded through CCLG. But what are they working on? Let's take a trip to Southampton to find out...
Joining forces to launch the North Star vision for children and young people diagnosed with cancer
Children's Cancer and Leukaemia Group (CCLG) has come together with Young Lives vs Cancer, Ellen MacArthur Cancer Trust, and Teenage Cancer Trust to ensure children and young people with cancer get the care and support they deserve.
Family learns about their funded research through Leeds lab visit
The family behind the Harley Staples Cancer Trust (HSCT) visited the University of Leeds earlier this week to learn more about acute lymphoblastic leukaemia (ALL) research they funded through Children’s Cancer and Leukaemia Group (CCLG) in 2023.
New leukaemia research funded in memory of Enfield schoolboy
Children's Cancer and Leukaemia Group Special Named Fund, A Goal for Sam, funds new leukaemia research.
CCLG Research Talks: How might immunotherapy improve outcomes for bone tumours?
Hear from Dr Jonathan Fisher about how immunotherapy could help children with solid tumours.
What is it like getting involved in childhood cancer research as a parent?
There is a lot more to research than just scientists in white lab coats. We caught up with some of the amazing parents who help shape the direction of childhood cancer research.
Delivering packaged drugs into paediatric brain tumours using ultrasound
Diffuse midline glioma is a devastating brain tumour, affecting primarily young children. There’s currently no cure for this disease and treatment options are limited. This is mainly because this type of tumour is well-protected from drugs by the ‘blood-brain barrier’. This barrier physically blocks all medications from entering the brain. Our group has developed new methods of bypassing this barrier using focused ultrasound.
"The first day back at school was scary, but exciting"
Lily Morris was diagnosed with acute lymphoblastic leukaemia (ALL) in 2022 aged 15. Now 16, she tells us about its impact on her GCSE preparations, and the support she’s received from her school and friends as she transitioned back into full-time education.